DESKTOP III Trial Results: Do patients in recurrent ovarian cancer benefit from cytoreductive surgery?

ENYGO, ESGO
8/12/20, 9:00 PM
Europe/Paris GMT+2

Description

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

​

DESKTOP III Trial Results: Do patients in recurrent ovarian cancer benefit from cytoreductive surgery?

Inglês

 

Speakers

Andreas du Bois

 

Link to the Event

https://enygo.esgo.org/watch/webinars/

Banner to the Event

DESKTOP III Trial Results: Do patients in recurrent ovarian cancer benefit from cytoreductive surgery?